Cytokinetics Dirección
Dirección controles de criterios 3/4
El CEO de Cytokinetics' es Robert Blum , nombrado en Feb 2006, tiene una permanencia de 18.17 años. compensación anual total es $8.75M, compuesta por 9% salario y 91% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.32% de las acciones de la empresa, por valor de $22.54M. La antigüedad media del equipo directivo y de la junta directiva es de 3.1 años y 13.4 años, respectivamente.
Información clave
Robert Blum
Chief Executive Officer (CEO)
US$8.8m
Compensación total
| Porcentaje del salario del CEO | 9.0% |
| Permanencia del CEO | 18.3yrs |
| Participación del CEO | 0.3% |
| Permanencia media de la dirección | 3.2yrs |
| Promedio de permanencia en la Junta Directiva | 13.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Cytokinetics, Incorporated: Buyout Speculation Persists
Apr 01Cytokinetics: CEO Talks Down Buyout Prospects
Mar 16Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)
Jan 12An Intrinsic Calculation For Cytokinetics, Incorporated (NASDAQ:CYTK) Suggests It's 37% Undervalued
Oct 05
Analysts Are Betting On Cytokinetics, Incorporated (NASDAQ:CYTK) With A Big Upgrade This Week
May 07Analysts Are Betting On Cytokinetics, Incorporated (NASDAQ:CYTK) With A Big Upgrade This Week
Mar 03Cytokinetics, Incorporated's (NASDAQ:CYTK) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 20Newsflash: Cytokinetics, Incorporated (NASDAQ:CYTK) Analysts Have Been Trimming Their Revenue Forecasts
Dec 15Cytokinetics: Surprise Adcomm For Omecamtiv Causing Concern
Oct 17Cytokinetics gets monitoring panel's nod to continue phase 3 trial of ALS drug reldesemtiv
Oct 10Cytokinetics (NASDAQ:CYTK) Has Debt But No Earnings; Should You Worry?
Aug 23Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$9m | US$790k | -US$526m |
| Sep 30 2023 | n/a | n/a | -US$527m |
| Jun 30 2023 | n/a | n/a | -US$540m |
| Mar 31 2023 | n/a | n/a | -US$431m |
| Dec 31 2022 | US$9m | US$742k | -US$389m |
| Sep 30 2022 | n/a | n/a | -US$282m |
| Jun 30 2022 | n/a | n/a | -US$216m |
| Mar 31 2022 | n/a | n/a | -US$258m |
| Dec 31 2021 | US$6m | US$709k | -US$215m |
| Sep 30 2021 | n/a | n/a | -US$229m |
| Jun 30 2021 | n/a | n/a | -US$156m |
| Mar 31 2021 | n/a | n/a | -US$135m |
| Dec 31 2020 | US$5m | US$682k | -US$127m |
| Sep 30 2020 | n/a | n/a | -US$114m |
| Jun 30 2020 | n/a | n/a | -US$140m |
| Mar 31 2020 | n/a | n/a | -US$132m |
| Dec 31 2019 | US$3m | US$656k | -US$122m |
| Sep 30 2019 | n/a | n/a | -US$118m |
| Jun 30 2019 | n/a | n/a | -US$110m |
| Mar 31 2019 | n/a | n/a | -US$105m |
| Dec 31 2018 | US$3m | US$630k | -US$106m |
| Sep 30 2018 | n/a | n/a | -US$120m |
| Jun 30 2018 | n/a | n/a | -US$131m |
| Mar 31 2018 | n/a | n/a | -US$132m |
| Dec 31 2017 | US$3m | US$612k | -US$128m |
Compensación vs. Mercado: La compensación total ($USD8.75M) de Robert está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD8.28M).
Compensación vs. Ingresos: La compensación de Robert ha aumentado mientras la empresa no es rentable.
CEO
Robert Blum (59 yo)
18.3yrs
Permanencia
US$8,751,057
Compensación
Mr. Robert I. Blum has been Chief Executive Officer, President and Director of Cytokinetics, Incorporated since January 22, 2007 and serves as its Principal Financial Officer. Mr. Blum previously served as...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President | 18.3yrs | US$8.75m | 0.32% $ 20.7m | |
| VP & Chief Accounting Officer | 5yrs | US$1.04m | 0.020% $ 1.3m | |
| Executive Vice President of Research & Development | 11.9yrs | US$4.44m | 0.083% $ 5.3m | |
| Executive VP & Chief Commercial Officer | 3.2yrs | US$3.20m | 0.024% $ 1.5m | |
| Co-Founder & Member of Scientific Advisory Board | 26.8yrs | US$21.94k | sin datos | |
| Vice President of Sales & Operations | 2.7yrs | sin datos | sin datos | |
| Vice President of Corporate Finance and Financial Planning & Analysis | less than a year | sin datos | sin datos | |
| Senior Vice President of Global Supply Chain Operations & Technical Operations | no data | sin datos | sin datos | |
| VP & Chief Compliance Officer | 2.5yrs | sin datos | sin datos | |
| VP, Associate General Counsel & Corporate Secretary | no data | sin datos | sin datos | |
| Senior Vice President of Global Marketing & Commercial Strategy | 3yrs | sin datos | sin datos | |
| Vice President of Human Resources | no data | sin datos | sin datos |
3.2yrs
Permanencia media
59yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CYTK se considera experimentado (3.1 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President | 17.3yrs | US$8.75m | 0.32% $ 20.7m | |
| Co-Founder & Member of Scientific Advisory Board | no data | US$21.94k | sin datos | |
| Independent Director | 11.3yrs | US$529.02k | 0.0095% $ 612.9k | |
| Independent Director | 13.5yrs | US$524.02k | 0.0095% $ 612.9k | |
| Co-Founder & Chairman of Scientific Advisory Board | 16.1yrs | US$41.50k | sin datos | |
| Independent Director | 3.5yrs | US$519.02k | 0.012% $ 740.8k | |
| Independent Chairman | 15.3yrs | US$559.02k | 0.026% $ 1.7m | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 7.8yrs | US$942.23k | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
13.5yrs
Permanencia media
69.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de CYTK son experimentados ( 13.4 años antigüedad media).